Kindred Biosciences Inc Asset Turnover Ratio (KIN), as of second quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kindred Biosciences Inc   (NASDAQ: KIN)
 

Kindred Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kindred Biosciences Inc 's asset turnover ratio, the ratio that measures the ability of Kindred Biosciences Inc 's assets to generate revenue, sequentially decreased to 0.08 in the second quarter (Jun 30 2021), which does not come as a surprise, as the Kindred Biosciences Inc continue to experience difficult business climate.

Within sector 185 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2021 compared to the preceding quarter from 3385 to 3414.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KIN Asset Turnover Ratio (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Asset Change -4.33 % 18.61 % -17.38 % -17.94 % -2.8 %
Y / Y Revenue Change -91.06 % 297.18 % -32.12 % -5.53 % 3101.21 %
Asset Turnover Ratio (TTM) 0.08 0.42 0.42 0.4 0.38
KIN's Total Ranking # 3414 # 3385 # 3385 # 3526 # 3382
Seq. Asset Change -1.01 % 17.84 % -9.26 % -9.62 % 22.73 %
Seq. Revenue Change 47.68 % 151.84 % -8.82 % -97.36 % 6461.69 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 186
Healthcare Sector # 493
Overall Market # 3414

Asset Turnover Ratio Statistics
High Average Low
0.41 0.2 0.03
(Mar 31 2021)   (Jun 30 2019)




KIN Company Profile • Back to KIN Efficiency Comparisons • Compare KIN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2021 Assets at quarter ending Jun 30 2021
Pulmonx Corporation  0.20 $ 41.889  Millions$ 209.791  Millions
Rvl Pharmaceuticals Plc  0.20 $ 72.728  Millions$ 372.094  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 251.663  Millions$ 1,290.285  Millions
Sutro Biopharma Inc   0.19 $ 68.810  Millions$ 354.916  Millions
Palvella Therapeutics Inc   0.19 $ 23.734  Millions$ 122.888  Millions
Insmed Inc  0.19 $ 170.638  Millions$ 889.761  Millions
Elicio Therapeutics Inc   0.19 $ 14.252  Millions$ 76.138  Millions
Pulmatrix Inc   0.19 $ 10.016  Millions$ 54.102  Millions
Outset Medical Inc   0.18 $ 79.135  Millions$ 428.623  Millions
Twist Bioscience Corporation  0.18 $ 115.590  Millions$ 627.599  Millions
Clearside Biomedical Inc   0.18 $ 4.257  Millions$ 23.285  Millions
Vir Biotechnology Inc   0.18 $ 182.706  Millions$ 1,013.796  Millions
Invo Fertility Inc   0.17 $ 1.426  Millions$ 8.189  Millions
Quotient Limited  0.17 $ 43.544  Millions$ 253.495  Millions
Arrowhead Pharmaceuticals Inc   0.17 $ 107.638  Millions$ 634.182  Millions
Cytomx Therapeutics Inc   0.17 $ 66.420  Millions$ 392.611  Millions
Beone Medicines Ltd   0.17 $ 947.044  Millions$ 5,628.067  Millions
Schrodinger Inc   0.17 $ 120.740  Millions$ 721.976  Millions
Aptevo Therapeutics Inc   0.16 $ 9.367  Millions$ 57.799  Millions
Prothena Corporation Public Limited Company  0.16 $ 60.748  Millions$ 376.214  Millions
Guardant Health Inc   0.16 $ 323.651  Millions$ 2,043.129  Millions
Ocular Therapeutix Inc   0.15 $ 32.285  Millions$ 208.457  Millions
Sangamo Therapeutics Inc   0.15 $ 137.715  Millions$ 903.680  Millions
Aspira Women s Health inc   0.15 $ 5.980  Millions$ 39.749  Millions
Bionik Laboratories Corp   0.15 $ 1.607  Millions$ 10.909  Millions
Fortress Biotech Inc   0.15 $ 52.654  Millions$ 358.479  Millions
Aveo Pharmaceuticals Inc   0.15 $ 13.962  Millions$ 95.089  Millions
Korro Bio Inc   0.15 $ 35.265  Millions$ 240.191  Millions
Teladoc Health Inc   0.14 $ 1,486.656  Millions$ 10,265.423  Millions
Theravance Biopharma inc   0.14 $ 64.158  Millions$ 446.401  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.